3月17日晚间,康哲药业(00867.HK,股价8.44港元,市值206亿港元)发布2024年度业绩报告,公司全年实现营业收入74.69亿元,同比下降6.8%。公司全年实现净利润16.13亿元,剔除相关资产减值损失计提后的正常化净利润为17.14亿元。 《每日经济新闻》记者注意到,2007年至今,康哲药业在2023年首次出现营收和净利润均同比下滑,2024年公司营收再次下降,但降幅有所收窄。 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.